Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma (Q37299181)
scientific article published on 29 July 2009
Language:
(P31) (Q13442814)
(P50) (Q32649604)
(P304) 68
(P478) 7
(P577) Wednesday, July 29, 2009
(P921) (Q194908)
(P1433) (Q15716664)
(P1476) "Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma" (language: en)
(P2093) John M Kirkwood
Michael B Atkins
Theresa L Whiteside
William Gooding
Andreas Kovar
Stephen D Gillies
Oscar Kashala
Michael A Morse
(P2860) (Q36953492)
(Q34655265)
(Q36445957)
(Q33370628)
(Q33363235)
(Q35877006)
(Q34507305)
(Q27860904)
(Q37671685)
(Q34287952)
(Q40618350)
(Q41760276)
(Q41515811)
(Q46664276)
(Q44342919)
(Q48615588)
(Q71056366)
(Q71724707)
(Q77436967)
(Q61484607)
other details
description scientific article published on 29 July 2009

External Links